Febrile neutropenia and reduced dose intensity in patients with aggressive non-Hodgkin's lymphoma (NHL) treated with CHOP and CNOP.

被引：0
|
作者：
Dale, DC
Crawford, J
Agboola, O
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Duke Univ, Med Ctr, Durham, NC 27706 USA
[3] Univ Rochester, Med Ctr, Rochester, NY 14627 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6599
引用
收藏
页码：582S / 582S
页数：1
相关论文
共 50 条
  • [21] Evaluation of Relative Dose Intensity (RDI) by Age in Patients (pts) with Non-Hodgkin Lymphoma (NHL) Receiving Pegfilgrastim and CHOP Based Chemotherapy
    Balducci, Lodovico
    Mo, May
    Abella, Steve
    Saven, Alan
    BLOOD, 2012, 120 (21)
  • [22] Dose intensity as a treatment related variable in aggressive non-Hodgkin's lymphoma.
    Rodriguez, J
    Romaguera, J
    McLaughlin, P
    Hagemeister, F
    Rodriguez, M
    Cabanillas, F
    BLOOD, 1997, 90 (10) : 3947 - 3947
  • [23] Cost-effectiveness analysis of G-CSF in elderly patients with aggressive non-Hodgkin's lymphoma (NHL) receiving CHOP
    Lyman, GH
    Cosler, LE
    VALUE IN HEALTH, 2006, 9 (03) : A107 - A107
  • [24] Sphingosomal vincristine in chop ± rituximab:: A promising new treatment for patients with high risk untreated aggressive non-Hodgkin's lymphoma (NHL)
    Rodriguez, M
    Sarris, A
    Dang, N
    ANNALS OF ONCOLOGY, 2005, 16 : 209 - 209
  • [25] Severe neutropenia and relative dose intensity among patients <65 and ≥65 years with non-Hodgkin’s lymphoma receiving CHOP-based chemotherapy
    Lee S. Schwartzberg
    Mansoor Saleh
    Sadie Whittaker
    Esteban Abella
    Supportive Care in Cancer, 2014, 22 : 1833 - 1841
  • [26] Intensified CNOP versus CHOP in the treatment of aggressive non-Hodgkin's lymphomas: A randomized trial of the Hellenic cooperative lymphoma group.
    Pangalis, GA
    Vassilakopoulos, TP
    Michalis, E
    Roussou, P
    Repoussis, P
    Vrakidou, E
    Koratzis, J
    Symeonidis, A
    Grigorakis, V
    Stefanoudakis, E
    Stamatelou, M
    Bourantas, K
    Kalmantis, T
    Christopoulos, G
    Kokkinis, G
    Michalakeas, I
    Papayiannis, A
    BLOOD, 2001, 98 (11) : 342A - 342A
  • [27] Efficacy of standard CHOP chemotherapy in elderly patients with poor risk non-Hodgkin's lymphoma (NHL)
    Doorduijn, JK
    Van der Holt, B
    Breed, WPM
    Van der Hem, KG
    Van Imhoff, GW
    Kramer, MHH
    Kooy, MV
    Van Oers, MHJ
    Ossenkoppele, GJ
    Richel, DJ
    Roozendaal, KJ
    Van't Veer, MB
    Verdonck, LF
    Verhoef, G
    Wijermans, PW
    Sonneveld, P
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 149 - 149
  • [28] Self-reported quality of life in elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy
    Doorduijn, J
    Buijt, I
    Holt, B
    Steijaert, M
    Uyl-de Groot, C
    Sonneveld, P
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 75 (02) : 116 - 123
  • [29] Cost analysis of hospitalization for CHOP-rituximab therapy in patients with non-Hodgkin's lymphoma (NHL).
    Bonfort, P
    Queuille, E
    Camilleri, M
    Hequet, O
    Thieblemont, C
    Bureau, J
    Bouafia, F
    Coiffier, B
    Dumontet, C
    BLOOD, 2002, 100 (11) : 292B - 292B
  • [30] Breakthrough Febrile Neutropenia and Associated Complications in Non-Hodgkin's Lymphoma Patients Receiving Pegfilgrastim
    Ng, Jia Hui
    Ang, Xiu Yun
    Tan, Sze Huey
    Tao, Miriam
    Lim, Soon Thye
    Chan, Alexandre
    ACTA HAEMATOLOGICA, 2011, 125 (03) : 107 - 114
12345